Showing results (131-140 of 231) with videos related to

Sort By:
Pageof 24
Cancer Cell|November 16, 2005
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progressionSooryanarayana Varambally, Jianjun Yu, Bharathi Laxman, et al.
JAMA Dermatology|April 14, 2017
Molecular Profiling of Multiple Primary Merkel Cell Carcinoma to Distinguish Genetically Distinct Tumors From Clonally Related MetastasesKelly L Harms, Lorena Lazo de la Vega, Daniel H Hovelson, et al.
Virchows Archiv : an International Journal of Pathology|December 16, 2014
Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinomaJoshua I Warrick, Daniel H Hovelson, Anmol Amin, et al.
Head & Neck|February 6, 2016
Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencingBrittny N Tillman, Megan Yanik, Andrew C Birkeland, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 27, 2026
Rapid Decentralized Prostate Cancer Risk Stratification by Portable Liquid Biopsy Analysis within a Clinical Biosensor Validation FrameworkKevin M Koo, Grant Phillips, Sriganesh Srihari, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2003
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cellsCelina G Kleer, Qi Cao, Sooryanarayana Varambally, et al.
Science (New York, N.Y.)|October 29, 2005
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancerScott A Tomlins, Daniel R Rhodes, Sven Perner, et al.
Human Pathology|June 17, 2020
A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutationsTimothy I Miller, Nicholas A Zoumberos, Bryan Johnson, et al.
Human Pathology|August 7, 2014
HRAS mutations are frequent in inverted urothelial neoplasmsAndrew S McDaniel, Yali Zhai, Kathleen R Cho, et al.
Cancer Research|September 17, 2008
A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancerBo Han, Rohit Mehra, Saravana M Dhanasekaran, et al.
Pageof 24